Customer Support Unavailable Oct 2-5 🍎 Due to High Holidays

Prolia

$480.00

Denosumab (Prolia) is used to prevent osteoporosis.

-
+
I need a prescription

Prolia is one form of the generic drug denosumab. It is a human monoclonal antibody for osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumors of bone. Dosage Prolia is administered as an injection by professional healthcare providers. Please follow the doctor’s instructions and read the information on the manufacturer’s Product Insert leaflet that comes with the medication. Denosumab can carry serious health risks.

Brand Manufacturer: Amgen
Side Effects: Possible side effects of Prolia include: low calcium levels (especially if you have kidney problems) weakness constipation back pain muscle pain pain in your arms and legs anemia diarrhea skin problems (eczema, blisters, dry skin, peeling, redness, itching, small bumps) You may also be more likely to get a severe infection, such as skin, ear, stomach/gut, or bladder infection, while taking Prolia. Inform a doctor immediately if there are signs of infection while taking the medication, such as: fever/chills, night sweats red/swollen/tender/warm skin severe stomach or abdominal pain ear pain or drainage, trouble hearing frequent/painful/burning urination, or pink/bloody urine severe itching, burning, rash, blistering, peeling, or dryness of the skin cough or shortness of breath pinpoint purple or red spots under your skin flu symptoms weight loss Not all possible side effects can be listed here. If you experience any of these or other unexpected side effects, consult a healthcare provider immediately.
Indication: Prolia is one form of the generic drug denosumab. It has been approved for the reduction of the risks of bone fractures in people with: Postmenopausal osteoporosis (especially spinal and hip fractures) Osteoporosis in men treated with surgery or medication for prostate cancer with resulting androgen deprivation Bone loss associated with long-term systemic glucocorticoid therapy Bone loss in women with breast cancer due to aromatase inhibitor-induced estrogen depletion (low estrogen levels)

Reviews

Write a review

The product has no reviews

Leave your review

Sign-up our newsletter to get update information, news, insight or promotions.

Categories

All products

Add Patient